RUOZI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.272
EU - Europa 16.863
AS - Asia 14.223
SA - Sud America 2.016
AF - Africa 357
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 24
Totale 64.805
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.860
GB - Regno Unito 4.992
IT - Italia 4.101
SG - Singapore 4.075
CN - Cina 4.052
SE - Svezia 3.137
HK - Hong Kong 1.846
BR - Brasile 1.544
VN - Vietnam 1.526
DE - Germania 947
UA - Ucraina 653
TR - Turchia 650
RU - Federazione Russa 639
FI - Finlandia 604
FR - Francia 552
KR - Corea 489
IN - India 365
BG - Bulgaria 245
NL - Olanda 185
CA - Canada 173
ID - Indonesia 173
AR - Argentina 153
BD - Bangladesh 144
IQ - Iraq 136
MX - Messico 130
JP - Giappone 124
IE - Irlanda 114
ZA - Sudafrica 112
ES - Italia 104
RO - Romania 91
PK - Pakistan 89
BE - Belgio 85
PL - Polonia 83
AE - Emirati Arabi Uniti 74
CO - Colombia 72
EC - Ecuador 72
LT - Lituania 61
CH - Svizzera 49
VE - Venezuela 48
EG - Egitto 47
IR - Iran 45
MY - Malesia 43
AU - Australia 41
MA - Marocco 41
CL - Cile 38
PH - Filippine 38
UZ - Uzbekistan 37
PY - Paraguay 36
CZ - Repubblica Ceca 32
AT - Austria 30
IL - Israele 30
JO - Giordania 30
TN - Tunisia 30
SA - Arabia Saudita 29
DZ - Algeria 28
TH - Thailandia 28
NP - Nepal 24
PT - Portogallo 24
GR - Grecia 23
JM - Giamaica 23
KE - Kenya 22
TW - Taiwan 22
UY - Uruguay 19
AZ - Azerbaigian 17
ET - Etiopia 17
KZ - Kazakistan 17
EU - Europa 16
PE - Perù 16
BO - Bolivia 15
SN - Senegal 15
CR - Costa Rica 14
DK - Danimarca 14
KG - Kirghizistan 14
DO - Repubblica Dominicana 13
LB - Libano 13
RS - Serbia 13
AL - Albania 12
BY - Bielorussia 12
HU - Ungheria 12
TT - Trinidad e Tobago 12
NZ - Nuova Zelanda 9
OM - Oman 9
PA - Panama 9
KH - Cambogia 8
LY - Libia 8
PR - Porto Rico 8
PS - Palestinian Territory 8
QA - Qatar 8
CY - Cipro 7
HN - Honduras 7
HR - Croazia 7
LK - Sri Lanka 7
NO - Norvegia 7
AM - Armenia 6
EE - Estonia 6
KW - Kuwait 6
LA - Repubblica Popolare Democratica del Laos 6
MN - Mongolia 6
NG - Nigeria 6
BH - Bahrain 5
Totale 64.694
Salva come PNG Salva come JPEG
Città #
Southend 3.817
Santa Clara 2.803
Ashburn 2.801
Singapore 2.498
Fairfield 2.350
Stockholm 1.818
Hong Kong 1.815
Chandler 1.757
Woodbridge 1.635
Hefei 1.335
Chicago 1.292
Jacksonville 1.265
Houston 1.086
San Jose 1.003
Seattle 997
Wilmington 991
Dearborn 954
Ann Arbor 918
Beijing 812
Cambridge 798
Nyköping 775
Los Angeles 719
London 632
Modena 538
Ho Chi Minh City 499
Seoul 431
Salt Lake City 385
The Dalles 380
Izmir 359
Council Bluffs 355
Helsinki 355
Hanoi 339
New York 316
Milan 252
Princeton 249
Dallas 245
Sofia 234
Eugene 220
San Diego 212
Lauterbourg 203
Tampa 179
Rome 171
Moscow 168
Buffalo 162
Elk Grove Village 162
Bologna 157
São Paulo 143
Shanghai 141
Munich 126
Des Moines 119
Orem 118
Jakarta 116
Redwood City 112
Frankfurt am Main 107
Lancaster 105
Tokyo 97
Bremen 94
Dublin 90
Fremont 90
Falls Church 88
Phoenix 78
Columbus 76
Brussels 73
Reggio Emilia 73
Miami 71
Chennai 69
Sterling 69
Naples 66
Da Nang 59
Haiphong 59
Guangzhou 58
Florence 56
Dulles 54
Johannesburg 54
Warsaw 54
Amsterdam 51
Boardman 50
Baghdad 49
Parma 49
Brooklyn 48
Detroit 46
Montreal 45
Nanjing 44
Turin 44
Atlanta 43
Toronto 43
Como 42
Catania 39
Mexico City 39
Bari 37
Denver 37
Kent 37
Norwalk 37
Rio de Janeiro 37
Kansas City 35
Washington 34
Tulare 33
Boston 32
Manchester 32
Napoli 32
Totale 44.972
Salva come PNG Salva come JPEG
Nome #
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.028
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 574
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 502
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 489
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 465
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 456
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 454
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 451
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 434
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 426
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 426
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 420
Cationic liposomes for gene transfection 419
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 413
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 411
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 411
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 400
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 398
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 394
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 393
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 388
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 386
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 385
Amphiphilic ion pairs of tobramycin with lipoamino acids 379
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 374
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 371
Vegetable cells in Papanicolaou-stained cervical smears 367
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 364
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 364
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 362
Polymeric nanoparticles for the drug delivery to the central nervous system 361
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 360
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 356
Nanomedicine: the future for advancing medicine and neuroscience 355
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 355
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 352
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 347
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 347
Brain targeting with polymeric nanoparticles: which administration route should we take? 346
Protein corona and nanoparticles: How can we investigate on? 346
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 342
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 342
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 341
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
Nanoparticle transport across the blood brain barrier 338
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 338
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 338
Amphiphilic Erythromycin-Lipoamino Acid Ion Pairs: Characterization and In Vitro Microbiological Evaluation 333
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles 332
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 329
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 328
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 325
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 324
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 323
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 321
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 320
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 319
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid 317
Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design. 314
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 314
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 314
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 312
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 311
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 311
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 307
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 306
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 306
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 305
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 303
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 302
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 301
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 300
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 300
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 299
Functionalization of liposomes: microscopical methods for preformulative screening 299
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 298
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 298
Colloidal systems for CNS drug delivery 297
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 296
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 296
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 295
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 294
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 292
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 292
PLA/PLGA nanoparticles for sustained release of docetaxel 291
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 290
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 289
A solution and solid state study on 2-hydroxypropyl-beta-cyclodextrin complexation with hyodeoxycholic acid 286
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 285
Preformulative and formulative studies on inclusion complexes between cyclodextrins and ursodeoxycholic acid 280
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 280
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 270
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 269
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 268
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 265
Ketorolac tromethamine liposomes: Encapsulation and release studies 265
Application of poly-L-lactide screws in flat foot surgery: Histological and radiological aspects of bio-absorption of degradable devices 264
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 262
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 262
Blood-Brain Barrier crossing of high molecular weight molecules mediated by nanoparticles: a potential approach to treat neurological Lysosomal Storage Disorders 261
Totale 35.828
Salva come PNG Salva come JPEG
Categoria #
all - tutte 237.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 237.761
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021643 0 0 0 0 0 0 0 0 0 0 365 278
2021/20224.234 189 486 381 289 161 212 238 229 498 332 698 521
2022/20234.919 592 536 401 482 569 711 116 437 578 91 188 218
2023/20243.460 177 202 220 286 732 356 396 426 127 89 148 301
2024/202511.116 526 176 238 820 2.136 1.467 897 755 1.082 503 1.148 1.368
2025/202621.821 1.329 851 1.566 2.785 4.348 1.379 2.238 1.032 3.875 1.985 433 0
Totale 65.216